Amphastar pharmaceuticals receives fda approval for supplement to its abbreviated new drug application for sodium bicarbonate injection

Amphastar pharmaceuticals receives fda approval for supplement to its abbreviated new drug application for sodium bicarbonate injection, usp 8.4%, 50meq/50ml.

AMPH Ratings Summary

AMPH Quant Ranking